These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6291904)

  • 1. Increased secretion of vasopressin and adenosine 3',5'-monophosphate from hypothalamic-posterior pituitary units of spontaneously hypertensive rats.
    DeVito WJ; Miller M; Sutterer JR
    Endocrinology; 1982 Dec; 111(6):1958-63. PubMed ID: 6291904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin influences on vasopressin and oxytocin release: in vitro studies.
    Izdebska K; Ciosek J
    Neuropeptides; 2010 Aug; 44(4):341-8. PubMed ID: 20466422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Centrally administered galanin modifies vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of euhydrated and dehydrated rats.
    Ciosek J; Cisowska A
    J Physiol Pharmacol; 2003 Dec; 54(4):625-41. PubMed ID: 14726616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine biosynthesis and vasopressin and oxytocin secretion in the spontaneously hypertensive rat: an in vitro study of localized brain regions.
    Morris M; Ross J; Sundberg DK
    Peptides; 1985; 6(5):949-55. PubMed ID: 4080611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GABA-A agonist muscimol inhibits stimulated vasopressin release in the posterior pituitary of Sprague-Dawley, Wistar, Wistar-Kyoto and spontaneously hypertensive rats.
    Magnusson AM; Meyerson BJ
    Neuroendocrinology; 1993 Nov; 58(5):519-24. PubMed ID: 8115020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of vasopressin secretion by ETA and ETB receptors in compartmentalized rat hypothalamo-neurohypophysial explants.
    Rossi NF
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E535-41. PubMed ID: 14665445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of desmethylimipramine on the hypothalamic and neurohypophysial vasopressin content in pinealectomized male rats.
    Juszczak M; Guzek JW
    Exp Clin Endocrinol; 1987 Aug; 90(1):26-36. PubMed ID: 3666058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid treatment upregulates the hypothalamic vasopressinergic system of spontaneously hypertensive rats.
    Pietranera L; Saravia F; Roig P; Lima A; De Nicola AF
    Neuroendocrinology; 2004; 80(2):100-10. PubMed ID: 15475662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of cyclic nucleotides on vasopressin release from the isolated neural lobe of normal and dehydrated rats and the intact hypothalamo-neurohypophysial system.
    Mathison R; Lederis K
    Proc West Pharmacol Soc; 1976; 19():457-60. PubMed ID: 186812
    [No Abstract]   [Full Text] [Related]  

  • 10. Galanin influences vasopressin and oxytocin release from the hypothalamo-neurohypophysial system of salt loaded rats.
    Cisowska-Maciejewska A; Ciosek J
    J Physiol Pharmacol; 2005 Dec; 56(4):673-88. PubMed ID: 16391423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic 3'5'-adenosine monophosphate in the hypothalamo-neurohypophysial system of normal, NaCl-treated and lactating rats.
    Ruoff HJ; Mathison R; Lederis K
    Neuroendocrinology; 1976; 22(1):18-29. PubMed ID: 193064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic nucleotides and the release of vasopressin from the rat posterior pituitary gland.
    Vale MR; Hope DB
    J Neurochem; 1982 Aug; 39(2):569-73. PubMed ID: 6283027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ontogeny of opioid inhibition of vasopressin and oxytocin release in response to osmotic stimulation.
    Hartman RD; Rosella-Dampman LM; Emmert SE; Summy-Long JY
    Endocrinology; 1986 Jul; 119(1):1-11. PubMed ID: 3720659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells.
    Kageyama K; Hanada K; Iwasaki Y; Sakihara S; Nigawara T; Kasckow J; Suda T
    J Endocrinol; 2007 Nov; 195(2):199-211. PubMed ID: 17951532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hypothalamic and neurohypophysial vasopressor and oxytocic activities in stressed rats treated with haloperidol.
    Olczak S; Guzek JW; Stempniak B
    Exp Clin Endocrinol; 1987 Apr; 89(2):145-52. PubMed ID: 3609161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic action of atrial natriuretic factor to inhibit vasopressin secretion.
    Samson WK; Aguila MC; Martinovic J; Antunes-Rodrigues J; Norris M
    Peptides; 1987; 8(3):449-54. PubMed ID: 2958784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two-step mechanism by which corticotropin-releasing hormone releases hypothalamic beta-endorphin: the role of vasopressin and G-proteins.
    Burns G; Almeida OF; Passarelli F; Herz A
    Endocrinology; 1989 Sep; 125(3):1365-72. PubMed ID: 2527150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The NO synthase inhibitor L-NNA depresses neurohypophysial vasopressin but not its precursor amidating enzymes in salt-loaded rats.
    Skujins A; Thorn NA
    Acta Physiol Scand; 1995 Nov; 155(3):243-50. PubMed ID: 8619321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strain, age and sex differences in the release of vasopressin from the pituitary: a study in the spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rat.
    Magnusson K; Meyerson BJ
    Neuropeptides; 1996 Oct; 30(5):465-70. PubMed ID: 8923509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of beta-adrenergic blockade on the hypothalamic and neurohypophysial vasopressin and oxytocin content in pinealectomized male rats.
    Guzek JW; Juszczak M
    Exp Clin Endocrinol; 1987 Mar; 89(1):97-104. PubMed ID: 2885209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.